MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, GALT had -$3,609K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$3,609K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued interest on convertible ...
    • Stock-based compensation expense
    • Net proceeds from exercise of st...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Change in fair value of derivati...
    • Accounts payable, accrued expens...

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-5,046 -5,500 -8,184 -17,152
Amortization of right to use asset
-53 --
Stock-based compensation expense
686 195 496 968
Amortization of right to use lease asset
0 -0 12
Non-cash interest expense
156 183 215 696
Change in fair value of derivative liabilities
-983 220 2,205 1,121
Prepaid expenses and other assets
-140 479 -467 -428
Accounts payable, accrued expenses and other liabilities
-662 -2,458 -345 -3,239
Accrued interest on convertible debt - related party
1,831 1,756 1,604 2,875
Net cash from operating activities
-3,866 -6,042 -3,542 -14,291
Net proceeds from exercise of common stock options and warrants
-1,073 443 724
Net proceeds from issuance of common stock
-1,164 853 1,218
Net cash from investing activities
-0 --
Net proceeds from exercise of stock options
257 10,000 0 11,000
Net cash flows from financing activities
257 12,237 1,296 12,942
Net decrease in cash and cash equivalents
-3,609 6,195 -2,246 -1,349
Cash and cash equivalents, beginning of period
17,720 11,525 15,120 -
Cash and cash equivalents, end of period
14,111 17,720 11,525 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net proceeds fromexercise of stock options$257K Net cash flows fromfinancing activities$257K Net decrease in cashand cash...-$3,609K Canceled cashflow$257K Accrued interest onconvertible debt - related...$1,831K Stock-based compensationexpense$686K Non-cash interestexpense$156K Prepaid expenses andother assets-$140K Net cash fromoperating activities-$3,866K Canceled cashflow$2,813K Net loss-$5,046K Change in fair value ofderivative liabilities-$983K Accounts payable,accrued expenses and...-$662K

GALECTIN THERAPEUTICS INC (GALT)

GALECTIN THERAPEUTICS INC (GALT)